Australian preparation and dosing guide for long-acting S19A benzathine benzylpenicillin EXTENCILLINE® product 

Australian preparation and dosing guide for long-acting S19A benzathine benzylpenicillin BRANCASTER® product 

Dr Rosemary Wyber outlines a framework for reducing the burden of RHD among Aboriginal and Torres Strait Islander peoples in Australia.

This poster highlights the pathway from group A streptococcal infection to acute rheumatic fever to rheumatic heart disease. An earlier version of this poster was presented by RHDAustralia at the Australian Primary Health Nurses Conference in Adelaide, 4-6th April 2019. 

Training tool: Australian recommendations for managing ARF symptoms.

This document includes key information extracted from each chapter in the 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3.2 edition, March 2022). 

The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition) was developed and endorsed by expert stakeholders and an Aboriginal and Torres Strait Islander advisory group. It provides standards, recommendations and guidance for clinically sound and culturally safe care for people living with acute rheumatic fever and rheumatic heart disease. (The 2020 guideline replaces the 2nd edition which was published by RHDAustralia in 2012.)

Training tool: Australian recommendations for duration of secondary antibiotic prevention of ARF and echocardiographic follow-up based on the level of disease.

Training tool: Australian recommendations for managing pregnant women with RHD, based on level of risk to health.

Training tool: Australian recommendations for classifying and managing ARF and RHD based on severity of disease.